For research use only. Not for therapeutic Use.
Brentuximab vedotin (SGN-35; Adcetris,cAC10-vcMMAE) is an anti-CD30 antibody conjugated via a protease-cleavable linker to the potent anti-microtubule agent monomethyl auristatin E (MMAE). Brentuximab vedotin can be used for the research of relapsed and refractory Hodgkin lymphoma.
| Catalog Number | I047196 |
| Purity | ≥95% |
| Reference | [1] van de Donk NW, et al. MAbs. 2012;4(4):458-465. |
